You are here

STEM CELLS Journal Names Co-Editors

Comment

Discuss

Donald G. Phinney, PhD, is Professor of Immunology and Microbiology and Associate Director for Research at Tulane's Center for Gene Therapy. Professor Phinney investigates the basic biology of Mesenchymal Stem Cells and their potential use for treatment of chronic lung disease and disorders of the central nervous system. Studies in mice have spurred pre-clinical trials to evaluate the safety and efficacy of intracranial stem cell transplantation for the treatment of neurological sequelae resulting from lysosomal storage diseases.

Miodrag Stojkovic, PhD, is Deputy Director of Centro de Investigacion Principe Felipe and head of its Cellular Reprogramming Laboratory, Valencia, Spain. In September 2006, a team led by Professor Stojkovic announced derivation of Pluripotent Human Embryonic Stem Cells (hESC) from non-viable early human embryos that had stopped their cleavage. Using surplus and donated embryos, the scientists demonstrated that these arrested embryos could be used under suitable laboratory conditions for derivation of hESC. Published in STEM CELLS, the technique may help to understand and fight debilitating diseases.

 

 

About STEM CELLS(R)

STEM CELLS(R), the international journal of cell Differentiation and Proliferation, publishes original articles at the leading edge of stem cell research and regenerative medicine. Beginning its 26th year of publication in 2008, STEM CELLS(R) is the first journal devoted to this fast-paced field of research. Its Impact Factor, the highest of all journals devoted to the peer reviewed publication of stem cells literature, is 7.924. For more information, please visit http://www.StemCells.com or contact:

George Kendall
Director of Operations and Business Development
AlphaMed Press
318 Blackwell Street, Suite 260
Durham, NC 27701

E-mail: georgekendall@alphamedpress.com